0.00Open22.52Pre Close0 Volume0 Open Interest110.00Strike Price0.00Turnover848.95%IV-3.72%PremiumOct 4, 2024Expiry Date25.66Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9863Delta0.0035Gamma3.27Leverage Ratio-2.2052Theta-0.0002Rho-3.23Eff Leverage0.0004Vega
Dollar General Stock Discussion
Gapping up
$Bristol-Myers Squibb (BMY.US)$ Shares jumped 3.8% after the FDA approved Cobenfy as a new treatment for schizophrenia in adults, marking the first novel treatment for the mental disorder in several decades.
$Wynn Resorts (WYNN.US)$ Shares climbed 1.7% following an upgrade to overweight from equal weight by Morgan Stanley, which highlighted the company's strong fundamentals compared to its competitors...
No comment yet